Ayala Pharmaceuticals (AYLA) News Today → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free AYLA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAyala Pharmaceuticals (ADXS) Earnings Dates & Reportsinvesting.com - February 13 at 11:30 PMAyala Pharmaceuticals Stock (OTC:ADXS) Dividends: History, Yield and Datesbenzinga.com - December 21 at 11:58 PMAdvaxis, Inc.: Advaxis and Ayala Pharmaceuticals Complete Mergerfinanznachrichten.de - January 19 at 2:19 PMCancer treatment developers Ayala Pharmaceuticals and Advaxis complete mergerbizjournals.com - January 19 at 2:19 PMmarketbeat.com - January 19 at 6:04 AMAyala Pharmaceuticals Presents Poster on AL102 in Desmoid Tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meetingfinance.yahoo.com - November 17 at 8:14 AMAyala Pharmaceuticals Announces First Patient Dosed with AL102 in Phase 3 Segment of RINGSIDE Trial in Desmoid Tumorsfinance.yahoo.com - November 16 at 5:10 PMAyala Pharmaceuticals Announces First Patient Dosed with AL102 in Phase 3 Segment of RINGSIDE Trial in Desmoid Tumorsfinance.yahoo.com - November 16 at 5:10 PMRecap: Ayala Pharmaceuticals Q3 Earningsmsn.com - November 4 at 11:29 AMAyala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 4 at 11:29 AMAyala Pharmaceuticals, Inc. (AYLA) Reports Q3 Loss, Lags Revenue Estimatesfinance.yahoo.com - November 4 at 11:29 AMAutoZone To Rise Over 9%? Plus Roth Capital Slashes PT On This Stock By 96%markets.businessinsider.com - October 20 at 12:10 PMWhy United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Sessionmsn.com - October 19 at 4:07 PMAyala, Advaxis Mergebaystreet.ca - October 19 at 11:06 AMAyala Pharma, Advaxis Announce Merger - Quick Factsmarkets.businessinsider.com - October 19 at 11:06 AMCancer treatment developers Ayala Pharmaceuticals and Advaxis to mergebizjournals.com - October 19 at 11:06 AMLab Notes: 4 early stage life sciences firms close financing deals; 2 drug candidates get Fast Track approvalbizjournals.com - September 30 at 1:19 PMAyala Pharmaceuticals to Host Key Opinion Leader Webinar on Desmoid Tumorsfinance.yahoo.com - September 29 at 9:45 AMAyala Pharmaceuticals Announces Fast Track Designation Granted by US FDA for AL102 in Progressing Desmoid Tumorsfinance.yahoo.com - September 27 at 10:26 AMAyala Pharmaceuticals Selected to Present Efficacy and Tolerability Data on AL102 in Desmoid Tumors at the European Society for Medical Oncology (ESMO) 2022 Congressfinance.yahoo.com - August 24 at 11:54 AMPhiladelphia-area life sciences companies with the largest stock, market cap declines in first half of 2022bizjournals.com - August 2 at 10:03 PMAyala Pharmaceuticals Stock Nearly Triples on Twitter Post. Is it a Buy?nasdaq.com - July 27 at 5:14 AMAyala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment Newsnasdaq.com - July 26 at 6:34 PMHC Wainwright Believes Ayala's Initial Cancer Data Is Encouragingfinance.yahoo.com - July 6 at 4:06 PMAyala's Cancer Candidate Shrinks Tumor In Substantially All Patients In Late-Stage Studyfinance.yahoo.com - July 5 at 3:05 PMAyala Pharmaceuticals to Present at the 2022 Jefferies Global Healthcare Conferencefinance.yahoo.com - June 2 at 8:46 AMAyala Pharma To Report Phase II/III Study Of AL102 In Desmoid Tumors Around Mid-2022nasdaq.com - May 17 at 3:04 AMAyala Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 16 at 5:03 PMAyala Pharmaceuticals Announces Poster Presentation on AL101 at the 2022 American Society of Clinical Oncology (ASCO) Annual Meetingfinance.yahoo.com - April 27 at 1:49 PMAyala Pharmaceuticals GAAP EPS of -$2.80, revenue of $3.5Mseekingalpha.com - March 30 at 9:51 PMMaxim Group Trims Ayala Pharmaceuticals (NASDAQ:AYLA) Target Price to $12.00marketbeat.com - March 30 at 9:28 AMAyala Pharmaceuticals, Inc. (AYLA) Reports Q4 Loss, Tops Revenue Estimatesmsn.com - March 28 at 7:10 PMAyala Pharmaceuticals Reports Full-Year 2021 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 28 at 7:10 PMAyala Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conferencefinance.yahoo.com - March 9 at 9:00 AMAyala Pharmaceuticals (NASDAQ:AYLA) Will Have To Spend Its Cash Wiselyfinance.yahoo.com - March 3 at 8:41 AMAyala Pharmaceuticals Announces Completion of Enrollment in Part A of RINGSIDE, a Pivotal Phase 2/3 Study of AL102 in Desmoid Tumorsfinance.yahoo.com - February 23 at 12:20 PMAyala Pharmaceuticals, Inc. Common Stock (AYLA)nasdaq.com - January 19 at 11:33 PMBuy These 2 Small-Cap Stocks to Double Your Investment, Say Analystsfinance.yahoo.com - January 17 at 6:40 PMAyala Pharmaceuticals Inc Shares Fall 4.6% Below Previous 52-Week Low - Market Movernasdaq.com - January 13 at 7:29 PMAyala Pharmaceuticals Inc Shares Fall 4.3% Below Previous 52-Week Low - Market Movernasdaq.com - January 7 at 11:31 PMAyala Pharmaceuticals Announces Key Business Objectives for 2022finance.yahoo.com - January 4 at 12:27 PMAyala Pharmaceuticals (NASDAQ:AYLA) Raised to Buy at Zacks Investment Researchmarketbeat.com - December 28 at 5:51 PMAyala Pharmaceuticals (NASDAQ:AYLA) Downgraded to Hold at Zacks Investment Researchmarketbeat.com - December 9 at 6:01 PMHow Much Upside is Left in Ayala Pharmaceuticals, Inc. (AYLA)? Wall Street Analysts Think 116%finance.yahoo.com - November 18 at 12:57 PMAyala Pharmaceuticals, Inc. (AYLA) Reports Q3 Loss, Misses Revenue Estimatesfinance.yahoo.com - November 15 at 3:03 PMAyala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Updatefinance.yahoo.com - November 15 at 8:35 AMRural America is losing its pharmaciesyahoo.com - November 12 at 8:17 AMAyala Pharmaceuticals to Present at Jefferies London Healthcare Conferencefinance.yahoo.com - November 10 at 8:20 AMEarnings Preview: Ayala Pharmaceuticals, Inc. (AYLA) Q3 Earnings Expected to Declinenasdaq.com - November 9 at 5:07 PMAyala Pharmaceuticals Inc.barrons.com - October 7 at 11:31 PM Get Ayala Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AYLA and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. AYLA Media Mentions By Week AYLA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AYLA News Sentiment▼0.000.44▲Average Medical News Sentiment AYLA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AYLA Articles This Week▼00▲AYLA Articles Average Week Get Ayala Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AYLA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Creative Medical Technology News Titan Pharmaceuticals News Fresh Tracks Therapeutics News BioCardia News Palisade Bio News Finch Therapeutics Group News TRACON Pharmaceuticals News Kiromic BioPharma News Avalon GloboCare News Organovo News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AYLA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ayala Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
